Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: Current genotyping of EV71 does not reflect their antigenicity

Vaccine

Volumn 31, Issue 2, 2013, Pages 425-430

  Chen, Yixin ^a   Li, Chuan ^a   He, Delei ^a   Cheng, Tong ^a   Ge, Shengxiang ^a   Shih, James Wai Kuo ^a   Zhao, Qinjian ^a   Chen, Pei Jer ^b   Zhang, Jun ^a   Xia, Ningshao ^a  

^a XIAMEN UNIVERSITY   (China)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Antigenicity; EV71; Monoclonal antibody; Neutralizing; Typing; Vaccine

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY;

ANTIGENICITY; ARTICLE; CONTROLLED STUDY; EMBRYO; ENTEROVIRUS 71; GENOTYPE; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; WESTERN BLOTTING;

EID: 84984570507     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.032     Document Type: Article

References (25)

1. McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002, 26(1):91-107.
2. Plevka P., Perera R., Cardosa J., Kuhn R.J., Rossmann M.G. Crystal structure of human enterovirus 71. Science 2012, 336(6086):1274.
3. Wang X., Peng W., Ren J., Hu Z., Xu J., Lou Z., et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol 2012, 19(4):424-429.
4. Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010, 10(11):778-790.
5. Schmidt N.J., Lennette E.H., Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974, 129(3):304-309.
6. Zhang Y., Tan X.J., Wang H.Y., Yan D.M., Zhu S.L., Wang D.Y., et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol 2009, 44(4):262-267.
7. Li Y.P., Liang Z.L., Gao Q., Huang L.R., Mao Q.Y., Wen S.Q., et al. Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial. Vaccine 2012, 30(22):3295-3303.
8. Chang J.Y., Chang C.P., Tsai H.H., Lee C.D., Lian W.C., Ih Jen S., et al. Selection and characterization of vaccine strain for Enterovirus 71 vaccine development. Vaccine 2012, 30(4):703-711.
9. Tee K.K., Lam T.T., Chan Y.F., Bible J.M., Kamarulzaman A., Tong C.Y., et al. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol 2010, 84(7):3339-3350.
10. Yu H., Chen W., Chang H., Tang R., Zhao J., Gan L., et al. Genetic analysis of the VP1 region of enterovirus 71 reveals the emergence of genotype A in central China in 2008. Virus Genes 2010, 41(1):1-4.
11. Huang Y.P., Lin T.L., Kuo C.Y., Lin M.W., Yao C.Y., Liao H.W., et al. The circulation of subgenogroups B5 and C5 of enterovirus 71 in Taiwan from 2006 to 2007. Virus Res 2008, 137(2):206-212.
12. Tan X., Huang X., Zhu S., Chen H., Yu Q., Wang H., et al. The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One 2011, 6(9):e25662.
13. Xu J., Qian Y., Wang S., Serrano J.M., Li W., Huang Z., et al. EV71: an emerging infectious disease vaccine target in the Far East?. Vaccine 2010, 28(20):3516-3521.
14. Dong C., Liu L., Zhao H., Wang J., Liao Y., Zhang X., et al. Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys. Vaccine 2011, 29(37):6269-6275.
15. Liu C.C., Lian W.C., Butler M., Wu S.C. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine 2007, 25(1):19-24.
16. Arita M., Nagata N., Iwata N., Ami Y., Suzaki Y., Mizuta K., et al. An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol 2007, 81(17):9386-9395.
17. Bek E.J., Hussain K.M., Phuektes P., Kok C.C., Gao Q., Cai F., et al. Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection. Vaccine 2011, 29(29-30):4829-4838.
18. Liang Z., Mao Q., Gao Q., Li X., Dong C., Yu X., et al. Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines. Vaccine 2011, 29(52):9668-9674.
19. Zhang Y., Zhu Z., Yang W., Ren J., Tan X., Wang Y., et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 2010, 7:94.
20. Xu F., Yan Q., Wang H., Niu J., Li L., Zhu F., et al. Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis. PLoS One 2010, 5(6):e11388.
21. Chung Y.-C., Ho M.-S., Wu J.-C., Chen W.-J., Huang J.-H., Chou S.-T., et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008, 26(15):1855-1862.
22. Kung S.H., Wang S.F., Huang C.W., Hsu C.C., Liu H.F., Yang J.Y. Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998-2005. Clin Microbiol Infect 2007, 13(8):782-787.
23. Mizuta K., Aoki Y., Suto A., Ootani K., Katsushima N., Itagaki T., et al. Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine 2009, 27(24):3153-3158.
24. Ong K.C., Devi S., Cardosa M.J., Wong K.T. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol 2010, 84(1):661-665.
25. Mao Q., Li N., Yu X., Yao X., Li F., Lu F., et al. Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71. Arch Virol 2012, 157(1):37-41.